Document is current
Any future updates will be listed below
-
Authors
Bollman, Brooke
Nunna, Naveen
Bahl, Kapil
Hsiao, Chiaowen Joyce https://orcid.org/0000-0001-8961-7522
Bennett, Hamilton
Butler, Scott
Foreman, Bryant
Burgomaster, Katherine E.
Aleshnick, Maya
Kong, Wing-Pui
Fisher, Brian E.
Ruckwardt, Tracy J. https://orcid.org/0000-0002-0007-7169
Morabito, Kaitlyn M. https://orcid.org/0000-0002-4849-4690
Graham, Barney S.
Dowd, Kimberly A.
Pierson, Theodore C.
Carfi, Andrea
- License Information
-
More Information
Article History
Received: 12 October 2022
Accepted: 29 March 2023
First Online: 20 April 2023
Competing interests
: B.B., N.N., K.B., C.J.H., H.B., and A.C. are employees of Moderna, Inc., and hold stock/stock options in the company. T.C.P., K.A.D., B.S.G., and W.-P.K. are inventors on patent applications describing the VRC5283 DNA vaccine (U.S. patent application number 16/334,099 and PCT/2018/018809). TCP is supported by the Division of Intramural Research, NIAID, NIH. S.B., B.F., K.E.B., M.A., B.E.F., T.J.R., and K.M.M. have no conflicts.
